Ironwood Pharma Raises $50 Million
Ironwood Pharmaceuticals Inc. (f.k.a. Microbia), a Cambridge, Mass.-based antibacterial drug company focused on gastrointestinal disorders, has raised $50 million in seventh-round funding. Morgan Stanley Investment Management led the round, and was joined by “numerous investors from previous financing rounds.” The company has now raised over $250 million in total VC funding since 1998, from firms like Morgan Stanley, Ridgeback Capital, Fidelity Biosciences, Paperboy Ventures, Polaris Venture Partners and Venrock.
2 October 2008•4 mins read
